NHTC Q2 Revenue Plunges 23% on China Weakness; Board Resumes Buybacks
NHTC sits 22% above its 52-week low of $1.55.
Summary
Natural Health Trends reported a 23% revenue decline to $7.6M and a net loss of $451K ($0.05/share) for Q2 2026, reversing a small profit a year ago. The direct seller cited cautious consumer spending in China and member conduct violations in Hong Kong as key drags. Active members fell to 26,000, deepening the operational challenges. The board authorized resuming share repurchases with ~$16M available, a potential support for the stock. Restructuring delivered $300K in cost savings in Q2, with more expected in H2. The results follow a Q1 loss and a 14% sales drop, confirming a deteriorating trend. With a market cap of only $15.6M, the buyback could be material, but the core business remains under severe pressure.
At the time of this announcement, NHTC was trading at $1.89 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $15.6M. The 52-week trading range was $1.55 to $5.10. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.